New 52 Week Low Today

Pieris Pharmaceuticals Inc PIRS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 4:00 PM EDT
11.24quote price arrow down-0.44 (-3.77%)
Volume
80,805
52 week range
10.82 - 80.80
Loading...
  • Open11.28
  • Day High11.59
  • Day Low10.82
  • Prev Close11.68
  • 52 Week High80.80
  • 52 Week High Date06/13/23
  • 52 Week Low10.82
  • 52 Week Low Date05/02/24

Key Stats

  • Market Cap13.90M
  • Shares Out1.24M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta0.76
  • YTD % Change-22.8

KEY STATS

  • Open11.28
  • Day High11.59
  • Day Low10.82
  • Prev Close11.68
  • 52 Week High80.80
  • 52 Week High Date06/13/23
  • 52 Week Low10.82
  • 52 Week Low Date05/02/24
  • Market Cap13.90M
  • Shares Out1.24M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta0.76
  • YTD % Change-22.8

RATIOS/PROFITABILITY

  • EPS (TTM)-23.18
  • P/E (TTM)-0.48
  • Fwd P/E (NTM)-43.23
  • EBITDA (TTM)-6.417M
  • ROE (TTM)-89.76%
  • Revenue (TTM)42.81M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-57.33%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/08/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Pieris Pharmaceuticals Inc

 

Profile

MORE
Pieris Pharmaceuticals, Inc. is a biotechnology company, which discovers and develops Anticalin-based drugs to target validated disease pathways. The Company’s clinical pipeline consists of immuno-oncology (IO), bispecific in partnership with collaborators, including S095012 (also referred to as PRS-344) targeting PD-L1 and 4-1BB, SGN-BB228 (also referred to as PRS-346) targeting CD228 and 4-1BB, and BOS-342 (also referred to as PRS-342) targeting GPC3 and 4-1BB. Its...
James Geraghty J.D.
Independent Chairman of the Board
Stephen Yoder
President, Chief Executive Officer, Director
Thomas Bures
Chief Financial Officer, Senior Vice President
Address
225 Franklin Street, 26Th Floor
Boston, MA
02110
United States

Top Peers

SYMBOLLASTCHG%CHG
ENZN
Enzon Pharmaceuticals Inc
0.075-0.0098-11.5566%
DTIL
Precision BioSciences Inc
10.84+0.36+3.44%
MTEM
Molecular Templates Inc
1.71+0.06+3.64%
TBIO
Telesis Bio Inc
0.3536-0.0021-0.5904%
EQ
Equillium Inc
1.56+0.10+6.85%